A thorough review of the RAVE and RITUXIVAS trials to assess the efficacy and possibility of using rituximab as induction therapy for ANCA-associated vasculitides.

**************************************

Estimated Time to View: 45 minutes
Title: Rituximab versus Cyclophosphamide for ANCA-associated vasculitis: A review of RAVE and RITUXIVAS Trials
Author: Reginald Obi, MD
Author Type: Fellow
Citation: Nephrology On-Demand 2011
Date Created: 2011
Revisions: None Indicated
Disclaimers: None
Resource Type: Video

Recommend to a Colleague/Friend

**************************************

LEARNING OPTIONS:

To view the interactive video, click here
To view this video using an iPad or iPhone, see below



Transparent Peer Review

GD Star Rating
loading...


To learn more about our 6-point transparent peer review system, click here



Share

Comments

  • Nephrology On-Demand Plus


    Our full-featured iOS app for the iPhone and iPad. NOD + integrates
    1. kidney education,
    2. training, and
    3. recruitment

    into a streamlined and user-friendly interface.


    Available_on_the_App_Store_(black)

  • Kidney Konnection


    A newsletter that discusses sophisticated topics in Nephrology for physicians in Internal Medicine.
    Click here to access your complimentary subscription
More in General Nephrology, Glomerulonephritides (37 of 212 articles)